Open Access

Concentration-dependent effect of silymarin on concanavalin A-stimulated mouse spleen cells in vitro


Cite

Figure 1

The effect of silymarin on CoA-activated mouse spleen cells in vitro: (a) proliferation index of T lymphocytes; (b) viability test of T lymphocytes using trypan blue staining. Significantly different values between CoA alone and CoA + silymarin treated groups are indicated as *p < 0.05, **p < 0.01, ***p < 0.001.
The effect of silymarin on CoA-activated mouse spleen cells in vitro: (a) proliferation index of T lymphocytes; (b) viability test of T lymphocytes using trypan blue staining. Significantly different values between CoA alone and CoA + silymarin treated groups are indicated as *p < 0.05, **p < 0.01, ***p < 0.001.

Figure 2

The effect of silymarin on cytokine secretion and mRNA levels in control unstimulated splenocytes and CoA-activated mouse spleen T lymphocytes in vitro: (a) concentration of IFN-γ and (b) IL-4 in supernatants of cells after 70 h cultivation; (c) relative gene expression for IFN-γ and (d) IL-4 in T lymphocytes after 70 h of cultivation. Significantly different values are indicated as: *p < 0.05, **p < 0.01, ***p < 0.001.
The effect of silymarin on cytokine secretion and mRNA levels in control unstimulated splenocytes and CoA-activated mouse spleen T lymphocytes in vitro: (a) concentration of IFN-γ and (b) IL-4 in supernatants of cells after 70 h cultivation; (c) relative gene expression for IFN-γ and (d) IL-4 in T lymphocytes after 70 h of cultivation. Significantly different values are indicated as: *p < 0.05, **p < 0.01, ***p < 0.001.

Figure 3

The effect of silymarin on mRNA levels in control unstimulated splenocytes and CoA-activated mouse spleen T lymphocytes in vitro for (a) transcription factor NF-κB and (b) transcription factor Foxp3. Significantly different values are indicated as *p < 0.05, **p < 0.01, ***p < 0.001.
The effect of silymarin on mRNA levels in control unstimulated splenocytes and CoA-activated mouse spleen T lymphocytes in vitro for (a) transcription factor NF-κB and (b) transcription factor Foxp3. Significantly different values are indicated as *p < 0.05, **p < 0.01, ***p < 0.001.

Figure 4

The effect of silymarin on mitochondrial membrane potential in naïve and CoA-activated mouse spleen cells and after treatment with silymarin (b), expressed as the mean intensity of fluorescence (MIF) for Rhodamine 123: (a) representative plots of MIF for control and individual silymarin-treated groups. Significantly different values are indicated as: *p < 0.05.
The effect of silymarin on mitochondrial membrane potential in naïve and CoA-activated mouse spleen cells and after treatment with silymarin (b), expressed as the mean intensity of fluorescence (MIF) for Rhodamine 123: (a) representative plots of MIF for control and individual silymarin-treated groups. Significantly different values are indicated as: *p < 0.05.

Figure 5

The proportions of live, early apoptotic, and late apoptotic/dead cells determined for the suspensions of naïve splenocytes, CoA-activated T lymphocytes, and following in vitro treatment with silymarin after 70 h of cultivation (b). Representative flow cytometric dot plots showing Annexin V and propidium iodide staining of naïve splenocytes and CoA-activated cells following silymarin treatment (a). Significantly different values between CoA alone and silymarin-treated groups for early apoptotic cells are indicated as *p < 0.05 and for live cells are indicated as Ñp < 0.05.
The proportions of live, early apoptotic, and late apoptotic/dead cells determined for the suspensions of naïve splenocytes, CoA-activated T lymphocytes, and following in vitro treatment with silymarin after 70 h of cultivation (b). Representative flow cytometric dot plots showing Annexin V and propidium iodide staining of naïve splenocytes and CoA-activated cells following silymarin treatment (a). Significantly different values between CoA alone and silymarin-treated groups for early apoptotic cells are indicated as *p < 0.05 and for live cells are indicated as Ñp < 0.05.
eISSN:
1338-6786
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Pharmacy, other